A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer.

Trial Profile

A Randomized Trial Of Raloxifene Plus Zoladex For Prevention Of Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2016

At a glance

  • Drugs Goserelin (Primary) ; Raloxifene (Primary)
  • Indications Breast cancer; Osteoporosis
  • Focus Therapeutic Use
  • Acronyms IBIS-RAZOR; RAZOR
  • Most Recent Events

    • 08 Dec 2012 Results presented at the 35th Annual San Antonio Breast Cancer Symposium.
    • 02 Dec 2011 Actual end date (May 2005) added as reported by ISRCTN: Current Controlled Trials.
    • 16 May 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top